Invega Sustenna (paliperidone palmitate) is a prescription drug that’s used to treat schizophrenia and schizoaffective disorder. Invega Sustenna is given as an injection into your muscle by a ...

Schizophrenia after adequately treated with Invega Sustenna (1-month paliperidone palmitate ext-rel inj susp) for at least 4 months, or with Invega Trinza (3-month paliperidone palmitate ext-rel ...

J&J's current daily oral formulation, monthly injectable Invega Sustenna product and three-monthly depot Invega Trinza brought in sales of $1.9 billion in the first six months of this year.

Schizophrenia after adequately treated with Invega Sustenna (1-month paliperidone palmitate ext-rel inj susp) for at least 4 months. Establish tolerability with Invega Sustenna prior to initiating.

That includes Johnson & Johnson's blockbuster Invega (paliperidone) range, which includes once-monthly (Invega Sustenna), three-monthly (Invega Trinza) and six-monthly version (Invega Hafyera), as ...

If you are worried about using this medicine, speak to your doctor or pharmacist. INVEGA HAFYERA contains the active ingredient paliperidone palmitate. INVEGA HAFYERA is used to treat ...

This leaflet answers some of the common questions about Invega Trinza. It does not contain all of the available information. It does not take the place of talking to your doctor or pharmacist.